Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

G1 Therapeutics Inc (NQ: GTHX )

20.83 USD +0.16 (+0.77%)
Official Closing Price Updated: 5:48 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about G1 Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
G1 Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021
From GlobeNewswire News Releases
G1 Therapeutics Announces Appointment of William C. Roberts as Vice President, Investor Relations & Corporate Communications
From GlobeNewswire News Releases
Peek Under The Hood: IEIH Has 17% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of February 2021 Options Trading For G1 Therapeutics (GTHX)
Investors in G1 Therapeutics Inc (GTHX) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GTHX... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags EVLO Penny Stocks CDNA
From Benzinga
G1 Therapeutics Presents Final Phase 2 Clinical Data on Trilaciclib in Combination with Chemotherapy in Metastatic Triple-Negative Breast Cancer Demonstrating Significant Improvement in Overall Surviv
Company also presents updated monotherapy data on investigational oral selective estrogen receptor degrader (SERD) rintodestrant for ER+, HER2- breast cancer 
From GlobeNewswire News Releases
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags GTHX FREQ PACB
From Benzinga
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ... 
Tags ONCY News IPHA
From Benzinga
70 Biggest Movers From Yesterday
Gainers China Automotive Systems, Inc. (NASDAQ: CAAS) shares surged 174.2% to close at $10.50 on Monday after the company ... 
Tags NKLA AMRH NBAC
From Benzinga
Mid-Day Market Update: Crude Oil Down Over 1%; Nikola Shares Plunge
Midway through trading Monday, the Dow traded down 1.21% to 29,547.12 while the NASDAQ fell 0.50% to 12,145.24. The S&P also fell, ... 
Tags Earnings KNDI Eurozone
From Benzinga
46 Stocks Moving In Monday's Mid-Day Session
Gainers China Automotive Systems, Inc. (NASDAQ: CAAS) shares jumped 60% to $6.13 after the company announced a significant ... 
Tags FTIV SNSS AMRH
From Benzinga
Bullish Two Hundred Day Moving Average Cross - GTHX
In trading on Monday, shares of G1 Therapeutics Inc (GTHX) crossed above their 200 day moving average of $15.41, changing hands as high as $17.74 per share. G1 Therapeutics Inc shares are currently... 
Tags Stocks
From Market News Video
Return On Capital Employed Overview: G1 Therapeutics
During Q3, G1 Therapeutics (NASDAQ: GTHX) brought in sales totaling $26.60 million. However, earnings decreased 68.38%, resulting in a ... 
Tags News Small Cap GTHX
From Benzinga
Mid-Morning Market Update: Markets Open Lower; S&P Global To Buy IHS Markit For $44B
Following the market opening Monday, the Dow traded down 0.95% to 29,626.44 while the NASDAQ fell 0.12% to 12,190.71. The S&P also ... 
Tags Benzinga Penny Stocks Global
From Benzinga
Thinking about trading options or stock in Tesla, G1 Therapeutics, Apple, Micron Technology, or At Home Group?
InvestorsObserver issues critical PriceWatch Alerts for TSLA, GTHX, AAPL, MU, and HOME. 
From PR Newswire
G1 Therapeutics to Participate in the Evercore ISI 3rd Annual HealthCONx Conference on December 3, 2020
From GlobeNewswire News Releases
Last Week's Notable Insider Buys: Avis, Biglari And More
Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders ... 
Tags NHI G1 Therapeutics GSKY
From Benzinga
Implied LABU Analyst Target Price: $102
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
G1 Therapeutics to Present Clinical Data on Trilaciclib and Rintodestrant at 2020 San Antonio Breast Cancer Symposium (SABCS)
From GlobeNewswire News Releases
G1 Therapeutics to Present at the Stifel Virtual Healthcare Conference on November 18, 2020
From GlobeNewswire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RGEN ADAP TBPH
From Benzinga
Recap: G1 Therapeutics Q3 Earnings
Shares of G1 Therapeutics (NASDAQ:GTHX) rose 2.7% in after-market trading after the company reported Q3 results. Quarterly ... 
Tags GTHX Market News Benzinga
From Benzinga
G1 Therapeutics Provides Third Quarter 2020 Corporate and Financial Update
From GlobeNewswire News Releases
The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags JAGX KIDS OPT
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags SNDX CLVS ELAN
From Benzinga
G1 Therapeutics to Provide Third Quarter 2020 Corporate and Financial Update on November 4, 2020
From GlobeNewswire News Releases
How The Parts Add Up: IWO Targets $274
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Interesting GTHX Put And Call Options For December 18th
Investors in G1 Therapeutics Inc (GTHX) saw new options become available this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GTHX... 
Tags Stocks
From Market News Video
G1 Therapeutics to Present Data on Trilaciclib at North America Conference on Lung Cancer (NACLC)
From GlobeNewswire News Releases
12 Healthcare Stocks Moving In Friday's After-Market Session
Gainers Collegium Pharmaceutical (NASDAQ:COLL) stock surged 6.32% to $23.7 during Friday's after-market session. This security ... 
Tags After/Hours Center PHAS EYES
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.